Patents by Inventor Bostjan Petek

Bostjan Petek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200179288
    Abstract: The present invention refers to pellets comprising pharmaceutically active ingredient and binder. Further, the invention refers to a process for preparing said pellets, to the use of said pellets for preparing a pharmaceutical composition, and to a dosage form comprising said pellets or pharmaceutical composition. Finally, the present invention refers to a dosage from for use in a method of treating a disease selected from the group consisting of gastro esophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome and for prevention of upper gastrointestinal bleeding in people who are at high risk.
    Type: Application
    Filed: September 5, 2017
    Publication date: June 11, 2020
    Applicant: Sandoz AG
    Inventors: Rok Staric, Bostjan Petek
  • Publication number: 20200163882
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 28, 2020
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Andrija Lebar, Petra Draksler, Bostjan Petek, Jerneja Opara, Klemen Naversnik, Petra Bozic
  • Publication number: 20170258761
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a dry pharmaceutical composition comprising Canagliflozin, as well as to a process for preparing the same. Such dry pharmaceutical composition is useful as a medicament, especially for the normalization of plasma glucose levels.
    Type: Application
    Filed: August 28, 2015
    Publication date: September 14, 2017
    Applicant: Sandoz AG
    Inventors: Mateja Burjak, Tanja Rozman Peterka, Bostjan Petek, Bostjan Markun, Katja Berginc, Miha Tomaz Jaklic, Rok Grahek, Zoran Ham
  • Publication number: 20160346207
    Abstract: The present invention belongs to the field of pharmaceutical industry and relates to a solid pharmaceutical composition comprising androgen receptor antagonists, e.g. Enzalutamide or ARN-509, as well as to processes for preparing the same. The solid pharmaceutical compositions are useful in the treatment of prostate cancer.
    Type: Application
    Filed: February 4, 2015
    Publication date: December 1, 2016
    Applicant: Lek Pharmaceuticals d.d.
    Inventors: Rok Grahek, Andrija Lebar, Petra Draksler, Bostjan Petek, Jerneja Opara, Klemen Naversnik, Petra Bozic